PMID: 11910600Mar 26, 2002Paper

Migraine in a specialist menopause clinic

Climacteric : the Journal of the International Menopause Society
E A MacGregor, D Barnes

Abstract

Epidemiological studies suggest that migraine and headache worsen during the climacteric. The authors noted that women attending a specialist hospital-based menopause clinic frequently reported vasomotor and other common climacteric symptoms but few spontaneously reported headache or migraine. The aim of this study was to assess the prevalence of migraine and headache in women attending this clinic. Seventy-four women consecutively attending the menopause clinic at St. Bartholomew's Hospital were questioned about headache. Those with a positive response were further interviewed to obtain a headache diagnosis. Headache was found to be a common symptom affecting 57% of women in the 3 months before attending a specialist menopause clinic. Migraine affected 29% of patients in the preceding 3 months. This condition was associated with significant disability: 80% of women reported that attacks were more frequent than once a month; 75% reported that the attacks were severe; 50% reported that the duration of treated attacks was longer than 1 day. The high prevalence of headache and migraine in this group suggests that perimenopausal women should routinely be asked about headache and offered appropriate advice. This should include optim...Continue Reading

References

Jul 1, 1978·Headache·L DennersteinG J Hyman
Feb 1, 1977·Acta Neurologica Scandinavica·B Hindfelt, O Nilsson
Nov 15, 1991·American Journal of Epidemiology·W F StewartD Ziegler
Jan 1, 1991·Journal of Clinical Epidemiology·B K RasmussenJ Olesen
Dec 13, 1986·British Medical Journal·B de LignièresM G Bousser
Dec 13, 1986·British Medical Journal·G D Wright, M K Patel
Nov 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·A L MagosJ W Studd
Aug 1, 1995·Mayo Clinic Proceedings·M P EvansJ M Evans
Jan 1, 1993·Journal of Neurology·H J Kaiser, O Meienberg
Feb 1, 1996·Cephalalgia : an International Journal of Headache·E A MacGregor
Feb 1, 1997·Neurologic Clinics·E A MacGregor
Apr 24, 1999·Cephalalgia : an International Journal of Headache·A MacGregor
Mar 31, 2001·Headache·A MacGregor

❮ Previous
Next ❯

Citations

Nov 1, 2008·Current Pain and Headache Reports·E A MacGregor
Sep 5, 2009·Current Pain and Headache Reports·E Anne MacGregor
Dec 20, 2008·Current Treatment Options in Neurology·E Anne MacGregor
Feb 27, 2004·Cephalalgia : an International Journal of Headache·G MazzottaP Sarchielli
Aug 9, 2006·Menopause : the Journal of the North American Menopause Society·Rossella E NappiGiuseppe Nappi
Jan 22, 2010·International Journal of Clinical Practice·A J Larner
Nov 16, 2007·Journal of Women's Health·Merle Diamond
Mar 8, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Rossella E Nappi, Giuseppe Nappi
Mar 26, 2002·Climacteric : the Journal of the International Menopause Society·J HodsonF al-Azzawi
Nov 2, 2012·Climacteric : the Journal of the International Menopause Society·L M LucchesiL Bittencourt
Nov 28, 2002·Headache·Michele PetersMargaret Murphy
Oct 11, 2007·The Journal of Family Planning and Reproductive Health Care·E Anne MacGregor
Feb 16, 2006·CNS Drugs·Avi Ashkenazi, Stephen D Silberstein
Aug 17, 2020·Menopause : the Journal of the North American Menopause Society·Carolyn Bernstein, Mary A O'Neal
May 26, 2009·Menopause International·Rossella E NappiFranco Polatti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.